BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Q, Sun Y, Yin X, Li J, Xie J, Xie M, Wang K, Wu S, Li Y, Hussain M, Jiang B, Liu Y, Huang C, Tao J, Zhu J. Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death. ACS Appl Bio Mater 2020;3:3378-89. [DOI: 10.1021/acsabm.0c00299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang N, Li J, Gao W, Zhu W, Yan J, He Z, Li L, Wu F, Pu Y, He B. Co-Delivery of Doxorubicin and Anti-PD-L1 Peptide in Lipid/PLGA Nanocomplexes for the Chemo-Immunotherapy of Cancer. Mol Pharm 2022. [PMID: 35994700 DOI: 10.1021/acs.molpharmaceut.2c00611] [Reference Citation Analysis]
2 Xu S, Shi X, Ren E, Zhang J, Gao X, Mu D, Liu C, Liu G. Genetically Engineered Nanohyaluronidase Vesicles: A Smart Sonotheranostic Platform for Enhancing Cargo Penetration of Solid Tumors. Adv Funct Materials 2022;32:2112989. [DOI: 10.1002/adfm.202112989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhu W, Bai Y, Zhang N, Yan J, Chen J, He Z, Sun Q, Pu Y, He B, Ye X. A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer. J Mater Chem B 2021;9:4201-10. [PMID: 33997867 DOI: 10.1039/d1tb00537e] [Reference Citation Analysis]
4 Castillo RR, Vallet-Regí M. Emerging Strategies in Anticancer Combination Therapy Employing Silica-Based Nanosystems. Biotechnol J 2021;16:e1900438. [PMID: 33079451 DOI: 10.1002/biot.201900438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]